Work

Real-world efficacy and safety analysis on three-day continuous intravenous pump infusion of endostar combination therapy for advanced NSCLC

Year: 2024

Type: conference-abstract

Source: Lung Cancer

DOI: 10.1183/13993003.congress-2024.pa5124

Authors: Guogang Xie, Xue Zhang, Wuping Bao, Aihua Bao, Yan Zhou, Yingying Zhang, Min Zhang

Institutions: Shanghai Jiao Tong University, Shanghai First People's Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404096241

Cites:

Cited by:

Related to: 10